Sonoma Pharma: Surges after COVID-19 disinfectant approved in Australia

Sonoma Pharmaceuticals

29/05/2020 10:07

** Drug developer's shares  SNOA.O  more than double to
$11.30 premarket
    ** SNOA on Thursday after hours said its disinfectant &
sanitizer received approval to be entered in Australian Register
of Therapeutic Goods for use against COVID-19  urn:newsml:reuters.com:*:nBw53jNY9a
    ** The product label claims 30-second kill time for viruses
on hard surfaces
    ** Product sold in Australia by MicroSafe Care Australia 
    ** SNOA recently acquired exclusive rights of the non-toxic
disinfectant, sold in Australian market under brand name
Nanocyn, from MicroSafe Group
    ** Up to Thursday's close, stock rose ~24% YTD

 (Reporting by Mrinalika Roy in Bengaluru)
 ((mrinalika.roy@thomsonreuters.com; within U.S. +1 646 223
8780, outside U.S. +91 806749 8325;))